Skip to main content
SpringerLink
Log in

Strategies for Optimizing Cytokine Treatment of Malignancies: Determination of Interferon Sensitivity in Chronic Myelocytic Leukemia

  • Conference paper
Leukemias

  • 82 Accesses

Abstract

Interferons (IFNs) comprise a heterogenous group of cytokines with pleiotropic activities. The mode of action of IFNs in human disease is still poorly understood. In particular it is not established whether IFNs exert their antineoplastic activity by direct interaction with tumor cells or indirectly by enhancing host antitumor responses. Nor is it known which biological features of a tumor and which host factors determine the sensitivity of malignant diseases to IFN therapy. In order to select IFN-α-sensitive tumor patients we have chosen Philadelphia chromosome- (Ph1)-positive chronic myelocytic leukemia (CML) as a model disease.

This work was financially supported by the Austrian Funds Zur Förderung der wissenschaflichen Forschung, project no. 6526.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Broxmeyer HE, Lu L, Platzer E, Feit C, Juliano L, Rubin BY (1983) Comparative analysis of the influences of human gamma, alpha and beta-interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol 131:1300–1305

    PubMed  CAS  Google Scholar 

  2. Calabretta B, Venturetti D, Kaczmarek L, Narni F, Talpaz M, Anderson B, Beran M, Baserga R (1986) Altered expression of G1-specific genes in human malignant myeloid cells. Proc Natl Acad Sci USA 83:1495–1498

    Article  PubMed  CAS  Google Scholar 

  3. Carlo-Stella C, Cazzola M, Ganser A, Bergamaschi G, Pedrazzoli P, Hoelzer D, Ascari E (1988) Synergistic antiproliferative effect of recombinant interferon-gamma with recombinant interferon-alpha on chronic myelogenous progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM). Blood 72:1293–1299

    PubMed  CAS  Google Scholar 

  4. Einat M, Resnitzky D, Kimchi A (1985) Close link between reduction of c-myc expression by interferon and Go/G1 arrest. Nature 313:597–600

    Article  PubMed  CAS  Google Scholar 

  5. Ferrari S, Narni F, Mars W, Kaczmarek L, Venturetti D, Anderson B, Calabretta B (1986) Expression of growth-regulated genes in human acute leukemias. Cancer Res 46:5162–5166

    PubMed  CAS  Google Scholar 

  6. Gastl G, Aulitzky W, Tilg H, Huber H, Hausmaninger H, Seewann HL, Coser C, Prinoth P, Huber C (1987) Dose-related effectiveness of alpha-interferon in chronic myelogenous leukemia. Blut 54:251–252

    Article  PubMed  CAS  Google Scholar 

  7. Geissler D, Lu L, Bruno E, Yang HH, Broxmeyer HE, Hoffman R (1986) The influence of T lymphocyte subsets and humoral factors on colony formation by human bone marrow and blood megakaryocyte progenitor cells in vitro. J Immunol 137: 2508–2513

    PubMed  CAS  Google Scholar 

  8. Greenberg PL, Mosney SA (1987) Cytotoxic effect of interferon in vitro on granulocytic progenitor cells. Cancer Res 37:1794–1799

    Google Scholar 

  9. Kelly K, Siebenlist U (1985) The role of c-myc in the proliferation of normal and malignant cells. J Clin Immunol 5:65–77

    Article  PubMed  CAS  Google Scholar 

  10. Konwalinka G, Geissler D, Peschel Ch, Tomaschek B, Schmalzl F, Huber H, Odavic R, Braunsteiner H (1982) A microagar culture system for cloning human erythropoietic progenitors. Exp Hematol 10:71–76

    PubMed  CAS  Google Scholar 

  11. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning. A laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor

    Google Scholar 

  12. Niederle N, Kloke O, Osieka R, Wandl U, Opalka B, Schmidt CG (1987) Interferon-alpha2b in the treatment of chronic myelogenous leukemia. Semin Oncol 14 (Suppl 2):29–35

    PubMed  CAS  Google Scholar 

  13. Oladipupo-Williams CK, Svet-Moldavskaya I, Vilcek J, Ohnuma T, Holland JF (1981) Inhibitory effects of human leukocyte and fibroblast interferons on normal and chronic myelogenous leukemia granulocytic progenitor cells. Oncology 38:356–360

    Article  Google Scholar 

  14. Talpaz M, Kantarjian HM, McCredie K, Trujillo JM, Keating MJ, Gutterman JU (1986) Hematologic remission and cytogenetic improvement induced by recombinant human interferon-alpha in chronic myelogenous leukemia. N Engl J Med 314: 1065–1069

    Article  PubMed  CAS  Google Scholar 

  15. Talpaz M, Kantarjian HM, McCredie KB, Keating MJ, Trujillo J, Gutterman (1987) Clinical investigation of human alpha interferon in chronic myelogenous leukemia. Blood 69:1280–1288

    PubMed  CAS  Google Scholar 

  16. Zarling JM, Eskra L, Borden EC, Horoszewicz J, Carter WA (1979) Activation of human natural killer cells cytotoxic for human leukemic cells by purified interferon. J Immunol 123:63–70

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University Hospital, A-6020, Innsbruck, Austria

    G. Gastl

Authors
  1. G. Gastl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Geissler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Leiter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Eibl
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Drach
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I. Lüttichau
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. Huber
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Innere Medizin, Abt. Hämatologie und Onkologie, Med. Akademie “Carl Gustav Carus”, Fetscherstrasse 74, 0-8019, Dresden, Germany

    J. Fleischer

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Gastl, G. et al. (1993). Strategies for Optimizing Cytokine Treatment of Malignancies: Determination of Interferon Sensitivity in Chronic Myelocytic Leukemia. In: Fleischer, J. (eds) Leukemias. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77083-8_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77083-8_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77085-2

  • Online ISBN: 978-3-642-77083-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation